Abstract:Background: Traumatic brain injury (TBI) sets in motion cascades of biochemical changes that result in delayed cell death and altered neuronal architecture. Studies have demonstrated that inhibition of glycogen synthase kinase-3 (GSK-3) effectively reduces apoptosis following a number of stimuli. The Wnt family of proteins, and growth factors are two major factors that regulate GSK-3 activity. In the absence of stimuli, GSK-3 is constitutively active and is complexed with Axin, adenomatous polyposis coli (APC), and casein kinase I alpha (CK1 alpha) and phosphorylates ss-Catenin leading to its degradation. Binding of Wnt to Frizzled receptors causes the translocation of GSK-3 to the plasma membrane, where it phosphorylates and inactivates the Frizzled co-receptor lipoprotein-related protein 6 (LRP6). Furthermore, the translocation of GSK-3 reduces ss-Catenin phosphorylation and degradation, leading to ss-Catenin accumulation and gene expression. Growth factors activate Akt, which in turn inhibits GSK-3 activity by direct phosphorylation, leading to a reduction in apoptosis.Methodology/Principal Findings: Using a rodent model, we found that TBI caused a rapid, but transient, increase in LRP6 phosphorylation that is followed by a modest decrease in ss-Catenin phosphorylation. Phospho-GSK-3 beta immunoreactivity was found to increase three days post injury, a time point at which increased Akt activity following TBI has been observed. Lithium influences several neurochemical cascades, including inhibiting GSK-3. When the efficacy of daily lithium was assessed, reduced hippocampal neuronal cell loss and learning and memory improvements were observed. These influences were partially mimicked by administration of the GSK-3-selective inhibitor SB-216763, as this drug resulted in improved motor function, but only a modest improvement in memory retention and no overt neuroprotection.Conclusion/Significance: Taken together, our findings suggest that selective inhibition of GSK-3 may offer partial cognitive improvement. As a broad spectrum inhibitor of GSK-3, lithium offers neuroprotection and robust cognitive improvement, supporting its clinical testing as a treatment for TBI.

Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Histone H3 Serine 10 is Involved in the Pathogenesis of Traumatic Brain Injury

ER stress mediated‑autophagy contributes to neurological dysfunction in traumatic brain injury via the ATF6 UPR signaling pathway

Unveiling the Role of PSD95 Phosphorylation after Traumatic Brain Injury: Insights from Phosphoproteomic Analysis

Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury.

Inhibition of RNF6 alleviates traumatic brain injury by suppressing STAT3 signaling in rats

Activation of Sphingosine 1-Phosphate Receptor 1 Enhances Hippocampus Neurogenesis in a Rat Model of Traumatic Brain Injury: An Involvement of MEK/Erk Signaling Pathway

Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo.

Involvement Of The Glycogen Synthase Kinase-3 Signaling Pathway In Tbi Pathology And Neurocognitive Outcome

Inhibition of TRPA1 attenuates oxidative stress-induced damage after traumatic brain injury via the ERK/AKT signaling pathway

Effect of C-Jun NH₂-terminal Kinase-Mediated P53 Expression on Neuron Autophagy Following Traumatic Brain Injury in Rats.

Inhibition of Transforming Growth Factor Beta-Activated Kinase 1 Confers Neuroprotection after Traumatic Brain Injury in Rats

N-Methyl-D-Aspartate Receptors Mediate Posttraumatic Increases Of Protein-Kinase-C In Rat-Brain

Activation of JAK2/STAT Pathway in Cerebral Cortex after Experimental Traumatic Brain Injury of Rats

Deletion of Mst1 Attenuates Neuronal Loss and Improves Neurological Impairment in a Rat Model of Traumatic Brain Injury

Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis Through the Camp/pka/nlrp3 Pathway

Upregulation of 3-MST Relates to Neuronal Autophagy After Traumatic Brain Injury in Mice

Effect of glycogen synthetase kinase 3 on rats' cognitive function after traumatic brain injury

Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice.

Single-cell RNA-sequencing analysis reveals enhanced non-canonical neurotrophic factor signaling in the subacute phase of traumatic brain injury

Endoplasmic reticulum stress and the unfolded protein response: emerging regulators in progression of traumatic brain injury

Upregulation of Sec22b plays a neuroprotective role in a rat model of traumatic brain injury via inducing protective autophagy